Literature DB >> 7518785

Expression of complement-regulatory proteins in normal and UW-preserved human liver.

J Y Scoazec1, D Delautier, A Moreau, F Durand, C Degott, J P Benhamou, J Belghiti, G Feldmann.   

Abstract

BACKGROUND/AIMS: Somatic cells are protected against complement-mediated injury by specialized membrane proteins, known as complement-regulatory proteins (CRP). The knowledge of the pattern of CRP expression in the liver is important to evaluate the role of complement-mediated injury in graft rejection.
METHODS: We determined the distribution of four main CRP: membrane cofactor protein (MCP), decay accelerating factor (DAF), protectin, and complement receptor 1 (CR1) in 30 histologically normal livers, 13 samples from University of Wisconsin cold-storage solution (UW)-preserved tissue and 17 postoperative biopsies of UW-preserved allografts.
RESULTS: In normal liver, hepatocytes expressed only MCP. Bile duct cells were reactive for MCP and protectin. Sinusoidal endothelial cells expressed MCP and protectin but displayed no or faint expression of DAF. Endothelial cells of portal vessels and centrilobular veins expressed high levels of DAF, MCP, and protectin. No expression of CR1 was observed. No change in CRP expression was usually detected after UW preservation, except for protectin, induced on hepatocytes in 9 samples of UW-preserved liver tissue and in 9 allografts.
CONCLUSIONS: Hepatocytes and sinusoidal endothelial cells, which have a defective expression of CRP, might be at risk for complement-mediated injury. However, this risk is not aggravated after UW preservation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518785     DOI: 10.1016/0016-5085(94)90178-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

2.  Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model.

Authors:  B H M Heijnen; I H Straatsburg; N D Padilla; G J Van Mierlo; C E Hack; T M Van Gulik
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver.

Authors:  L Bergamaschini; G Gobbo; S Gatti; L Caccamo; P Prato; M Maggioni; P Braidotti; R Di Stefano; L R Fassati
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 4.  Role of liver sinusoidal endothelial cells in liver diseases.

Authors:  Jordi Gracia-Sancho; Esther Caparrós; Anabel Fernández-Iglesias; Rubén Francés
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-15       Impact factor: 46.802

5.  Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.

Authors:  Zhidan Tu; Qing Li; Hong-Shiue Chou; Ching-Chuang Hsieh; Howard Meyerson; Marion G Peters; Hong Bu; John J Fung; Shiguang Qian; Lina Lu; Feng Lin
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

6.  Distribution of membrane cofactor protein (MCP/CD46) on pig tissues. Relevance To xenotransplantation.

Authors:  J M Pérez de la Lastra; S M Hanna; B P Morgan
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

7.  Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.

Authors:  N Kinugasa; T Higashi; K Nouso; H Nakatsukasa; Y Kobayashi; M Ishizaki; N Toshikuni; K Yoshida; S Uematsu; T Tsuji
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

Review 8.  Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function.

Authors:  Kelley Núñez; Paul Thevenot; Abeer Alfadhli; Ari Cohen
Journal:  Int J Mol Sci       Date:  2018-06-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.